Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-11

Clinical Trial Update: Does Dapagliflozin Provide Additional Health Benefits To Dietary Counseling For Weight Loss? [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating whether adding dapagliflozin to dietary counseling provides additional health benefits for weight loss; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Christopher Bell | Conditions: Weight Loss | Phase 2 | Status: COMPLETED | Results posted: 2020-02-11